We report on a restriction fragment-length polymorphism (HpyCH4III) assay for profile analysis of 23S rRNA gene A2058T-mutated alleles associated with high-level macrolide resistance in Moraxella catarrhalis. Our assay results were supported by DNA sequencing analysis, allowed for simultaneous testing of many strains, and produced results from pure-cultured colonies within 4 h.
CocoA., VernacchioL., HorstM., AndersonA.2010; Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics 125:214–220 [View Article][PubMed]
Debets-OssenkoppY. J., BrinkmanA. B., KuipersE. J., Vandenbroucke-GraulsC. M., KustersJ. G.1998; Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 42:2749–2751[PubMed]
IwataS., SatoY., ToyonagaY., HanakiH., SunakawaK.2015; Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones. J Infect Chemother 21:308–311 [View Article][PubMed]
KasaiA., OgiharaS., YamadaK., TanimichiY., NishiyamaH., SaitoR.2015; Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011. J Med Microbiol [Epub ahead of print]. [View Article][PubMed]
LiuY., ZhaoC., ZhangF., ChenH., ChenM., WangH.2012; High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China. Microb Drug Resist 18:417–426 [View Article][PubMed]
SeemungalT. A. R., WilkinsonT. M. A., HurstJ. R., PereraW. R., SapsfordR. J., WedzichaJ. A.2008; Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 178:1139–1147 [View Article][PubMed]
Tait-KamradtA., DaviesT., CronanM., JacobsM. R., AppelbaumP. C., SutcliffeJ.2000; Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 44:2118–2125 [View Article][PubMed]